Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008 by Lorusso, Alessio et al.
Genetic and antigenic characterization of H1
influenza viruses from United States swine from
2008
Alessio Lorusso,
1 Amy L. Vincent,
1 Michelle L. Harland,
1 David Alt,
1
Darrell O. Bayles,
1 Sabrina L. Swenson,
2 Marie R. Gramer,
3 Colin
A. Russell,
4 Derek J. Smith,
4 Kelly M. Lager
1 and Nicola S. Lewis
4
Correspondence
Amy L. Vincent
amy.vincent@ars.usda.gov
Received 28 September 2010
Accepted 19 December 2010
1Virus and Prion Disease Research Unit, USDA/ARS/NADC, Ames, IA, USA
2USDA/APHIS/NVSL, Ames, IA, USA
3University of Minnesota, St Paul, MN, USA
4Department of Zoology, University of Cambridge, Downing Street, Cambridge CB2 3EJ, UK
Prior to the introduction of the 2009 pandemic H1N1 virus from humans into pigs, four
phylogenetic clusters (a-, b-, c- and d) of the haemagglutinin (HA) gene from H1 influenza viruses
could be found in US swine. Information regarding the antigenic relatedness of the H1 viruses was
lacking due to the dynamic and variable nature of swine lineage H1. We characterized 12 H1
isolates from 2008 by using 454 genome-sequencing technology and phylogenetic analysis of all
eight gene segments and by serological cross-reactivity in the haemagglutination inhibition (HI)
assay. Genetic diversity was demonstrated in all gene segments, but most notably in the HA gene.
The gene segments from the 2009 pandemic H1N1 formed clusters separate from North American
swine lineage viruses, suggesting progenitors of the pandemic virus were not present in US pigs
immediately prior to 2009. Serological cross-reactivity paired with antigenic cartography
demonstrated that the viruses in the different phylogenetic clusters are also antigenically divergent.
INTRODUCTION
Influenza in swine is an acute respiratory disease caused by
influenza A virus. Influenza A virus contains a negative-
sense ssRNA genome organized into eight individual
segments, allowing for reassortment and production of
novel viruses (Lamb & Krug, 2007). Based upon the major
differences within the haemagglutinin (HA) and neurami-
nidase (NA) proteins, 16 HA and 9 NA subtypes, naturally
paired in different combinations, have been identified thus
far (Fouchier et al., 2005; Ro ¨hm et al., 1996; Webster et al.,
1992). HA and NA proteins are encoded by segments 4 and
6 of the viral genome, located on the virion surface, and are
the primary target for the host immune response (Skehel &
Wiley, 2000). The HA protein is the most important
determinant of virulence and host specificity as its binding
site and binding pocket recognize sialic acid-containing cell
surface receptors on host epithelial cells (Ayora-Talavera
et al., 2009; de Wit et al., 2010; Nicholls et al., 2008; Shinya
et al., 2006). The remaining six segments encode the
following structural and accessory proteins: PB2 (segment
1), PB1 (segment 2), PA (segment 3), NP (segment 5), M1
and M2 (segment 7), NS1 and NS2/NEP (segment 8) (Lamb
& Krug, 2007). An additional accessory protein PB1-F2
(Chen etal.,2001)canbeencoded bysegment 2aswellasthe
recentlyidentifiedproteinproductN40(Wise etal.,2009),of
which little is known. Accessory proteins may confer viru-
lence properties to viruses that express them (McAuley et al.,
2007); e.g. PB1-F2 associates with mitochondrial proteins,
inducing apoptosis in immune cells (Chen et al.,2 0 0 1 ;
Zamarin et al., 2006), and NS1 abrogates the expression of
antiviral genes in host cells (Garcı ´a-Sastre et al., 1998; Geiss
et al., 2002; Lipatov et al.,2 0 0 5 ;S e oet al.,2 0 0 4 ) .V i r u l e n c e
markers as well as factors contributing to inter-species
transmission were indentified in the PB2 protein (Gao et al.,
2009; Hatta et al., 2001; Mehle & Doudna, 2009; Salomon
et al., 2006; Steel et al., 2009; Subbarao et al.,1993; Tarendeau
et al., 2008; Yamada et al., 2010; Zhu et al., 2010), whereas
antiviral-resistance determinants were found in the NA (Le
et al., 2005) and M proteins (Marozin et al., 2002).
Classical H1N1 swine viruses (cH1N1), derived from the
1918 pandemic H1N1, were the unique subtype responsible
for infection of US swine (Easterday & van Reeth, 1999)
until the introduction of a novel H3N2 virus around 1998
changed the status quo of influenza epidemiology in US
swine (Vincent et al., 2008). The H3N2 viruses quickly
became endemic and then reassorted with extant cH1N1
The GenBank/EMBL/DDBJ accession numbers for the 2008 HI
sequences from segment 1 to segment 8 are presented in Table 2.
Supplementary tables are available with the online version of this paper.
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H3N2 viruses were demonstrated to have HA, NA and PB1
genes from viruses originating in humans; PA and PB2 genes
from viruses originating in avians; and the remaining internal
genes, NP, M and NS, of viruses originating in swine, thus
giving rise to the triple reassortant designation (Zhou et al.,
1999). The human lineage PB1, avian lineages PB2 and PA
and swine lineages NP, M and NS found in contemporary
influenza viruses of swine are referred to as the triple
reassortant internal gene (TRIG) constellation (Vincent et al.,
2008). Reassortant viruses have become endemic and co-
circulate in most major swine-producing regions of the USA
and Canada, including further drift variants of multiple
lineages of H3N2, H1N2 and H1N1 (Vincent et al., 2008).
Additionally, introduction of H1 in the TRIG backbone
viruses with the HA gene of human virus origin (hu-like H1)
thataregeneticallyandantigenicallydistinctfromtheclassical
swine H1 lineage were reported (Vincent et al., 2009a). There-
fore, in order to best represent the evolution of the currently
circulating H1 viruses, a cluster classification has been
proposed (Vincent et al., 2009a). Viruses from the cH1N1
lineage evolved over time to form a-, b-a n dc-clusters based
on the genetic makeup of the HA gene, whereas H1 subtype
strains with HA genes most similar to human seasonal H1
viruses form the d-cluster. All four HA cluster gene types can
be found with NA genes of either the N1 or N2 subtype.
The concern for the role of pigs in the evolution of
influenza A viruses was underscored after the outbreak in
humans of the novel 2009 pandemic H1N1. The 2009
pandemic H1N1 has been demonstrated to contain six
gene segments of the North American triple reassortant
swine lineage with the M and NA from the Eurasian lineage
H1N1 (Dawood et al., 2009; Garten et al., 2009). Thus,
further investigation regarding the genetic and antigenic
evolution of North American influenza virus isolates from
swine prior to the emergence of 2009 pandemic H1N1 was
warranted. Until recently, however, there were no estab-
lished tools for the quantitative analysis of antigenic data.
In the present study, we characterized 12 2008 field isolates
from swine of the H1 subtype influenza virus in two
parallel approaches. The first was based on the full genome
sequence and phylogenetic analysis of the eight viral gene
segments. The genome sequence analysis was carried out by
adopting the next generation 454 genome sequencing
technology. The second approach used serological cross-
reactivity in the haemagglutination inhibition (HI) assay
and antigenic cartography. To our knowledge, this study
offers the first antigenic mapping of H1 viruses currently
circulating in the swine population.
RESULTS
Pyrosequencing technology
The pyrosequencing technology was successfully applied to
multiplexed de novo sequencing of up to five viruses per
region by use of oligo adaptors containingmultiplex identifier
(MID). Because of the large number of non-influenza virus
sequence readsin preliminary sequencingefforts(background
RNA from culture source, i.e. MDCK cells) a two-step
sequential sucrose semi-purification was performed in the
final sequencing run. Additionally, a quantitative real-time
RT-PCR for the matrix gene (Spackman & Suarez, 2008) was
utilized to quantify influenza virus-specific RNA prior to
cDNA synthesis, and real-time PCR for the same matrix gene
target was used to semi-quantify viral cDNA just prior to
sequencing. The average percentage of the 12 viral genomes
sequenced by the Genome Sequencer was 79% of approxi-
mately 13500 bases. In most cases, large contigs were
assembled by the Newbler software for each gene segment
for each virus. Comparison of the large de novo contigs by
BLAST with known influenza sequences allowed lineage
identification for all genes. Sanger sequencing using targeted
oligo primers was utilized to walk across gaps or clean up
sequences. No large contigs were produced for gene segment
8 of A/swine/Ohio/02026/2008, which was subsequently
amplified by standard RT-PCR procedures for sequencing.
Genetic characterization
We analysed the virus sequences to elucidate the molecular
characteristics in those gene segments previously shown to
carry virulence factors. All 2008 H1 swine viruses carrying
the avian-lineage PB2, contained an E at position 627, a D
residue at position 701 and an R residue at position 591. By
sequence analysis of the human-lineage PB1 all viral isolates,
with the exception of one, contain the full-length coding
sequence for the accessory PB1-F2 product. A/swine/
Kentucky/02086/2008 had premature stop codons in the
PB1-F2 coding sequence after nine residues as in other
published PB1 sequences from extant swine viruses (data
not shown). All strains contained an N at position 66 of the
PB1-F2 mature product. S66 was reported to be associated
with increased virulence in the 1918 H1N1 virus and some
highly pathogenic H5N1 avian influenza viruses (Conenello
et al., 2007).
Comparison of the HA protein sequences was performed.
The 12 2008 H1 isolates contain residues typical of the
swine lineage in the receptor-binding pocket with some
exceptions: A/swine/Iowa/02039/2008 (d1 HA cluster)
showed an exclusively human lineage G residue at position
68 (according to H1 numbering of the mature peptide with
1 being the first amino acid after the signal sequence); A/
swine/Iowa/02039/2008 and A/swine/Texas/01976/2008 (d1
HA cluster) display 187N residue as in contemporary
H1N1/H1N2 human and swine viruses; d1 and d2 viruses
differ in position 133 with respect to the other clusters
showing a human-lineage S residue. Moreover, the
presence of 187D (or N) suggests a ‘human’ Neu5Aca2-
6Gal receptor binding preference (Matrosovich et al., 2000;
Neumann & Kawaoka, 2006). Residues of the receptor-
binding pocket and variability in the antigenic epitopes are
represented in Fig. 1.
A. Lorusso and others
920 Journal of General Virology 92Fig. 1. HA1 protein sequence alignment reveals critical amino acid changes between a-, b- c- and d-clusters. The 12 2008 H1 predicted HA1 proteins were aligned and
compared to that of 2009 pandemic H1N1 (A/MX/4108/2009, GenBank accession no. GQ162170) and A/swine/Minnesota/07002083/2007 (d2 cluster, GenBank
accession no. FJ611898) and numbered using the mature HA1. Two human seasonal influenza viruses HA sequences were included: A/Michigan/2/2003 (GenBank
accession no. CY016324) and A/Wisconsin/04/2009 (GenBank accession no. GQ475852). Amino acid differences are visible in the antigenic sites Cb (red), Ca2 (green),
Sa (light blue), Sb (violet) and Ca1 (yellow) between the a-, b-, c-cluster viruses and the human-like d-cluster viruses. The residues forming the receptor-binding pocket are
indicated by a diamond (e). Viruses belonging to the d-cluster preserve remnants of the human lineage. A/swine/Iowa/02039/2008 contains a G (blue) at position 68 and N
(violet in the Sb antigenic site) at position 187. The 187N human virus-derived residue is present in A/swine/Texas/01976/2008 as well.
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N1 viruses have been described to confer resistance to the
activity of oseltamivir(Le et al., 2005). Allthe 2008 H1 swine
viruses carrying the N1 gene contained the oseltamivir-
sensitive genotype. Residue 31S of the M2 protein was
previously shown to confer resistance to antiviral molecules
amantadine/rimantadine if mutated to an N residue in
European swine H1N1, H1N2 and H3N2 influenza viruses
(Marozin et al., 2002). The influenza isolates from US swine
analysed here displayed the amantadine-sensitive genotype.
The NS1 genes of the 2008 H1 strains do not possess the
deletion at position 80–84 or an E at position 92 previously
shown to act as virulence factors (Long et al., 2008; Seo
et al., 2002). The 2009 pandemic H1N1 was previously
shown to lack CPSF30-binding activity (Hale et al., 2010),
and all of the 2008 NS1 protein sequences from swine
viruses carry the same 108R, 125E and 189G residues
responsible for loss of binding, with the exception of a 189S
residue present in A/swine/Missouri/02060/2008.
Phylogenetic analysis
The phylogenetic analysis is shown in Fig. 2(a, b). The 12
selected H1 swine influenza viruses represent each of the
four previously described HA phylogenetic clusters found
in swine and all have the North American TRIG
constellation (Fig. 2a). In addition, the HA from the d-
cluster viruses were shown to have most likely emerged
from two separate introductions of human seasonal HA of
an H1N2 and an H1N1 (Vincent et al., 2009a) and can be
differentiated by two distinct subclusters, d1 and d2,
respectively (Fig. 2b). Variation was demonstrated in the
six genes that make up the TRIG, but no HA cluster-
specific patterns were detected among the TRIG genes.
Viruses belonging to the d-cluster were shown to be paired
either with an N1 or an N2 gene consistently of human
lineage. Importantly, none of the eight genes from the 2008
H1 viruses clustered with the genes of the 2009 pandemic
H1N1 that emerged in the human population in the spring
of 2009. In all of the phylogenetic analyses of each gene
segment, the pandemic H1N1 formed a distinct and
independent branch from the US swine lineage genes.
Antigenic characterization
Serological cross-reactivity in the HI assay is summarized in
Supplementary Tables S1(a, b), available in JGV Online, and
the fold-reduction between homologous and heterologous
serum and virus pairs is described in Supplementary Tables
S1(a, b). Viruses representing the phylogenetic clusters
evolved from the cH1N1 swine-lineage demonstrated
moderatetostrongcross-reactivitywithinacluster,especially
within recent b-a n dc-cluster viruses. However, cross-
reactivity between clusters was more variable, ranging from
no cross-reactivity to strong cross-reactivity. The lack of
cross-reactivity was most dramatically demonstrated
between the cH1N1 swine-lineage clusters and the d-cluster.
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924 Journal of General Virology 92Indeed, in four of five putative antigenic sites, the d-cluster
viruses contain unique amino acid residues making them
dramatically different from the other three clusters (Fig. 1).
Additional d-cluster viruses were tested against swine
influenza antisera by HI (J. R. Ciacci-Zanella and others,
unpublished data) and added to the antigenic cartography to
better place the 2008 d-cluster viruses. Limited HI cross-
reactivity was demonstrated within the d-cluster overall.
Future addition of d-cluster viruses and antisera willimprove
their placement in the swine H1 antigenic map. The 2008 H1
viruses tended tobemappedantigenicallyinaccordancewith
their phylogenetic cluster as demonstrated in Fig. 3, and
represent at least five antigenically distinct clusters of H1
viruses co-circulating in US swine in 2008.
Antisera generated against two isolates of 2009 pandemic
H1N1 were additionally tested against select 2007–2008
swine H1 viruses and results reported in Table 3(a, b) and
included in the antigenic cartography are depicted in Fig. 3.
Decreased fold-differences in cross-reactivity were evident
between the 2009 pandemic H1N1 antisera and a- and b-
cluster influenza isolates from US swine. Moderate cross-
reactivity was demonstrated between the 2009 antisera and
c-cluster swine isolates tested (Table 3a, b). No cross-
reactivity was found between 2009 pandemic H1N1
antisera and viruses belonging to the d-cluster (data not
shown). Cross-reactivity between swine influenza antisera
and 2009 pandemic H1N1 viruses was shown in a recent
study (Vincent et al., 2010). Three 2009 pandemic H1N1
isolated from swine (Supplementary Table S3, available in
JGV Online) were tested against the 2008 serum panel and
included in the antigenic cartography analysis. Human and
swine 2009 pandemic H1N1 isolates mapped together in
the antigenic cartography (Fig. 3).
DISCUSSION
The purpose of this study wasto characterize the genetic and
antigenic properties of 12 representative 2008 H1 influenza
viruses isolated from US swine. The viruses were collected
the year prior to the emergence and global spread of the
2009 pandemic H1N1 virus and represent the predominant
viruses circulating in US swine at that time. The 454 genome
sequencing technology described in this report was success-
fully applied to multiplexed de novo sequencing for nearly all
segments of each virus. Large contigs were generated that
allowed identification of the sequences as influenza A virus
as well as lineage determination. Recent reports using oligo
enrichment (Ramakrishnan et al., 2009) or amplicon
(Ho ¨per et al., 2009) based techniques for 454 sequencing
likelyimprovescoverage ofthefullinfluenzaA virusgenome
compared with the completely de novo method used here.
Advancement in next generation genome sequencing
continues to evolve as this relatively new technology is
applied to viral RNA genomes.
Genetic diversity was demonstrated in all gene segments,
but most notably in the HA gene with five distinct genetic
clusters (a-, b-, c-, d1 and d2). All a-, b- and c-cluster H1
viruses studied were paired with an N1 subtype of the
North American swine lineage. The three d1 were paired
with an N2 subtype. In contrast to HA, no patterns of
clustering according to H1 cluster could be extended to the
genes composing the TRIG. This suggests that reassortment
and drift of the H1 HA is occurring randomly on the TRIG
backbone. None of the d-cluster sequences used in the
phylogenetic analysis from our virus set or published
sequences were paired with a swine-lineage N1 as found for
viruses in the a-, b- and c-clusters. Thus, the human-
lineage d-cluster HA shows a unique preference for the
human-lineage N1 and N2. The human N2 gene was
introduced into pigs nearly 10 years ago (Vincent et al.,
2008) and is now well-established in the swine population.
The human-lineage N2 from the H3N2 viruses are closely
related to the NA genes of the seasonal human H1N2 from
which the d1 viruses evolved. An optimal ‘HA/NA pairing’
Fig. 3. Antigenic map of North American swine influenza viruses
subtype H1. The relative positions of strains (coloured dots) and
swine hyperimmune antisera (open squares) were computed such
that the distances between strains and antisera in the map with the
least error represent the corresponding HI measurements (Smith
et al., 2004). Strain colour indicates a-cluster (cyan), b-cluster
(pink), c-cluster (blue), d-cluster (gold) and 2009 H1N1 (red).
Each grid square represents 1 U of antigenic distance, corres-
ponding to a twofold difference in the HI assay.
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the virus in terms of transmission and replication
properties as confirmed by recent experiments in pigs
(Ma et al., 2010).
The influenza virus polymerase plays a critical role in the
adaptation ofavian virusestomammalians. Generally,aa627
inthePB2proteinisalmostexclusivelyKinhumaninfluenza
isolates and E in avian influenza isolates (Subbarao et al.,
1993). Additionally, the mutation E627K was found to be
responsible for host range, tissue tropism and increased
virulence of avian viruses in mammals (Fouchier et al., 2004;
Gao et al., 2009). In addition, a D701N amino acid change
has been found to confer high pathogenicity to an H5N1 in
experimentally infected mice (Li et al.,2 0 0 5 ) .M a m m a l i a n -
type residues K627 and N701 are found in some H5N1 or
H7N7 (Fouchier et al., 2004) and are implicated in
expanding the transmission range in ferrets (Van Hoeven
et al., 2009) and guinea pigs (Steel et al., 2009). The 2009
pandemic H1N1 possess E627 and an R591 that has been
recently recognized to sustain efficient replication in
mammalian cells, compensating for the lack of K627
(Mehle & Doudna, 2009; Yamada et al.,2 0 1 0 ) .O ft h e
publicly available swine TRIG PB2 sequences, approximately
30% contain R591 (Mehle & Doudna, 2009). Accordingly,
the entire panel of the 2008 TRIG H1 isolates reported in this
study contained PB2-R591, suggesting that this genotype
may be selected in the swine host. Additional PB2 sequence
analysis and evaluation in vivo in swine is warranted.
Antigenic cartography is a theory and associated com-
putational method that resolves the paradoxes in the
interpretation of antigenic data and makes possible
high-resolution quantitative analyses and visualization of
binding assay data (de Jong et al., 2007; Garten et al., 2009;
Table 1. 2008 UMVDL H1 swine influenza virus sequence
dataset from which the 12 2008 H1 viruses were selected
Pig location a-Cluster b-Cluster c-Cluster d-Cluster Total
USA
Iowa 0 11 6 14 31
Illinois 3 6 26 8 43
Indiana 0 0 1 0 1
Kansas 1 4 2 4 11
Kentucky 0 5 0 0 5
Michigan 0 0 1 1 2
Minnesota 6 58 16 48 128
Missouri 6 13 7 3 29
North Carolina 0 2 30 18 50
Nebraska 0 7 1 2 10
Ohio 0 0 11 5 16
Oklahoma 0 5 0 16 21
South Dakota 1 0 2 1 4
Texas 0 2 1 7 10
Wisconsin 0 3 5 1 9
Canada
Manitoba 4 0 0 0 4
Saskatchewan 1 0 0 0 1
Total 22 116 109 128 375
Table 2. 2008 H1 swine influenza viruses (left column) included in the genetic and antigenic study and previous H1 swine influenza
virus isolates used for the generation of antisera
Sequence GenBank accession numbers proceeding from segment gene 1 to segment gene 8 for each 2008 H1 isolate. Sw, Swine; p, pandemic.
2008 H1 GenBank accession nos Cluster Subtype NADC H1 Cluster Subtype
A/SW/MN/02053/2008 HM461759–HM461766 a H1N1 A/SW/MN/37866/1999 cH1 H1N1
A/SW/MN/02093/2008 HM461791–HM461798 a H1N1 A/SW/IA/1973 cH1 H1N1
A/SW/IA/02096/2008 HM461839–HM461846 b H1N1 A/SW/WI/1/1968 cH1 H1N1
A/SW/KY/02086/2008 HM461783–HM461790 b H1N1 A/SW/IA/1945 cH1 H1N1
A/SW/NE/02013/2008 HM461831–HM461838 b H1N1 A/SW/IA/15/1930 cH1 H1N1
A/SW/NC/02084/2008 HM461823–HM461830 b H1N1 A/SW/IA/00239/2004 b H1N1
A/SW/NC/02023/2008 HM461815–HM461822 c H1N1 A/SW/NC/36883/2002 b H1N1
A/SW/OH/02026/2008 HM461775–HM461782 c H1N1 A/SW/OH/511445/2007 c H1N1
A/SW/MO/02060/2008 HM461807–HM461814 c H1N1 A/SW/KS/00246/2004 c H1N2
A/SW/TX/01976/2008 HM461847–HM461854 d1 H1N2 A/SW/MN/00194/2003 c H1N2
A/SW/IA/02039/2008 HM461767–HM461774 d1 H1N2 A/SW/MN/1192/2001 c H1N2
A/SW/MN/02011/2008 HM461799–HM461806 d1 H1N2 A/SW/MN/07002083/2007 d2 H1N1
A/SW/NC/00573/2005 d2 H1N1
A/SW/IL/00685/2005 d2 H1N1
A/SW/IL07003243/2007 d1 H1N2
A/MX/4108/2009 2009p H1N1
A/CA/04/2009 2009p H1N1
A/SW/IL/5265/2009 2009p H1N1
A/SW/IL/32974/2009 2009p H1N1
A/SW/MN/8761/2010 2009p H1N1
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Smith et al., 2004). By using antigenic cartography and
phylogenetic analysis, we showed that five antigenic (a-, b-,
c-clusters, d1- and d2-subclusters) of H1 influenza A
viruses, co-circulate in the US pig population, but have
limited HI cross-reactivity between them. Antigenic cross-
reactivity was limited between H1 clusters and supports the
practice of combining multiple H1 viruses with H3N2
viruses in polyvalent vaccines used to control influenza in
US swine population as well as many other regions around
the world (http://www.aphis.usda.gov/animal_health/vet_
biologics/publications/CurrentProdCodeBook.pdf). Estab-
lished influenza viruses undergo antigenic drift in the swine
host, allowing survival and selection of certain viral clusters
in the host population. The H1 viruses will likely continue
to mutate and evolve in the swine host as a consequence
of evolutionary and immunological pressures, allowing
evasion of the immune system of the host or only partially
protective immunity. Further study is required to evaluate
the usefulness of antigenic mapping for vaccine strain
selection through experimental efficacy studies in pigs.
Our previous experiment (Vincent et al., 2010) demon-
strated cross-reactivity using 2009 H1N1 as antigen and
sera from pigs immunized with c-cluster swine viruses
from 2007 and 2008. The c-cluster is the clade with which
the HA from 2009 H1N1 is most closely related (Figs 2b
and 3). Thus, prior exposure to some H1 swine subtypes is
likely to provide some level of protection against infection
with the 2009 human pandemic variant. This is also
suggested by data from human epidemiological studies that
showed high prevalence of neutralizing antibodies against
2009 pandemic H1N1 in people born before 1930 (Itoh
et al., 2009; Munster et al., 2009). Moreover, immunization
in mice with human H1N1 viruses that circulated before
1945 (e.g. specific antibodies against 1918 H1N1 or related
viruses) is sufficient for immune protection from the 2009
pandemic H1N1 (Manicassamy et al., 2010).
The 2009 pandemic H1N1 underscores the potential risk to
the human population from additional influenza virus
subtypes and genotypes with the swine influenza TRIG
backbone and demonstrates the potential for viruses with
genes from swine lineages to emerge and cause human
illness. However, all eight gene segments from the 2009
pandemic H1N1 formed clusters separate from US swine
lineage viruses, suggesting neither the pandemic H1N1 nor
closely related progenitor viral genes were present in
influenza viruses from US swine prior to 2009.
Recent epidemiological data (M. R. Gramer and others,
unpublished data) suggest that the number of swine
influenza outbreaks in which d-cluster viruses were
recognized as causative agents increased in recent years
(up to 40% of isolated H1 swine influenza viruses in 2009
and early 2010), thus quickly becoming a dominant
genotype in the USA. An expanded antigenic map with
additional contemporary d-cluster isolates and further
investigation of their antigenic relationship with seasonal
human viruses are therefore warranted.
The presence of typical ‘human-like’ residues in the
receptor-binding pocket of the HA in two d-cluster strains
isolated from pigs demonstrates that swine viruses may
efficiently preserve human-adapted phenotypes. The pre-
servationofhuman-likeresiduesintheswinehostmayallow
potential novel reassortant influenza viruses to spill back
into the human population, and this may be particularly
important to consider for the d-cluster swine viruses.
Increased surveillance and monitoring by sequence and
antigenic analysis of enzootic influenza viruses of swine as
well as the 2009 pandemic H1N1 in the swine population
worldwidearecriticalforunderstandingthedynamicecology
of influenza A viruses in this susceptible host popula-
tion. Likewise, development of a vaccine strain selection
system throughsurveillanceand antigeniccharacterization of
Table 3. (a, b) HI titres for individual swine serum samples (a),
fold-reduction compared with homologous HI titre (b)
Reciprocal HI titres for individual serum samples against human
isolates of 2009 pandemic H1N1 are reported for 2007–2008 US H1
swine influenza viruses representing the swine-lineage a-, b-, and c-
clusters. p, Pandemic; phylogenetic clusters are indicated by the
corresponding letter in front of the virus or antiserum names.
Viruses Sera
p#960A p#962A p#963A p#966A
(a)
p A/CA/04/09 640* 640* 320 320
p A/MX/4108/09 640 640 640* 1280*
a A/Sw/MN/02053/08 10 40 20 20
a A/Sw/MN/02093/08 160 160 40 40
b A/Sw/IA/02096/08 80 80 80 40
b A/Sw/KY/02086/08 80 160 160 80
b A/Sw/NE/02013/08 40 20 80 20
b A/Sw/NC/02084/08 80 160 80 80
c A/Sw/NC/02023/08 160 160 160 160
c A/Sw/OH/02026/08 80 80 80 80
c A/Sw/MO/02060/08 80 80 80 40
c A/Sw/OH/511445/07 80 80 80 80
(b)
p A/CA/04/09 * * 2 2
p A/MX/4108/09 1 1 * *
a A/Sw/MN/02053/08 64 16 32 32
a A/Sw/MN/02093/08 4 4 16 16
b A/Sw/IA/02096/08 8 8 8 16
b A/Sw/KY/02086/08 8 4 4 8
b A/Sw/NE/02013/08 16 32 8 32
b A/Sw/NC/02084/08 8 4 8 8
c A/Sw/NC/02023/08 4 4 4 4
c A/Sw/OH/02026/08 8 8 8 8
c A/Sw/MO/02060/08 8 8 8 16
c A/Sw/OH/511445/07 8 8 8 8
*Homologous antiserum and virus reactions.
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influenza viruses and reducing the risk of such reassortment
events with the current 2009 pandemic H1N1 or other
emerging viruses in the future.
METHODS
Virus selection. Twelve H1N1 or H1N2 viruses representing each of
the genetic clusters of subtype H1 from 2008 were received from the
University of Minnesota Veterinary Diagnostic Laboratory (UMVDL)
for use in this study. The viruses were isolated from outbreaks of
respiratory disease in pigs from routine diagnostic cases submitted to
the UMVDL. Viruses isolated in 2008 from the USA and Canada were
selected from a database of 375 viral RNA sequences generated from
diagnostic cases, each 900 nt long, of the H1 subtype (Table 1). The
sequences were stored in a group database [Los Alamos National
Laboratory, Influenza Sequence Database (http://www.flu.lanl.gov/)]
and phylogenetic analyses were performed based on sequence
alignment by the CLUSTAL W method using the MEGALIGN program
from the Lasergene package (DNASTAR). From the phylogenetic
analyses of the HA1 region of the HA gene, 12 viruses were selected
for inclusion in this study to represent each of the H1 clusters of
influenza viruses from North American swine circulating in 2008.
Viruses were grown in Madin2Darby canine kidney (MDCK) cells in
culture. Inactivated viruses for immunization were prepared at
approximately 128 HA units per 50 ml (or maximum HA titre) with
inactivation by UV irradiation and addition of a commercial adjuvant
(Emulsigen D; MVP Laboratories) at a ratio of 4:1 (v/v) virus to
adjuvant. Virus isolates contained in the inactivated vaccines and
selected for full genome analysis are reported in Table 2. Similarly
prepared immune sera from additional studies conducted at USDA
NADC (Vincent et al., 2006, 2009a) were included in HI assays and
antigenic mapping and are described in Table 2.
454 genome sequencing technology. The 12 selected viruses from
clinical cases were grown at low passage number (P,5) in MDCK cell
culture, concentrated and semi-purified on a 0.5 M sucrose cushion.
Virus pellets were resuspended overnight at 4 uC in 0.5 ml STE buffer
(10 mM NaCl, 10 mM Tris, pH 8.0 and 1 mM EDTA, pH 8.0).
Resuspended virus samples were treated with 10 U RNase-free DNase
I (Promega) and incubated for 10 min at room temperature, then
treated with 500 U RNase inhibitor (RNase-In; Ambion) and 5 mlo f
0.1 M dithiothreitol (Invitrogen). An equal volume of 26 LES buffer
(0.2 M LiCl, 10 mM EDTA and 2.0% SDS) was added to each
sample, treated with 200 mg proteinase K (Invitrogen) and incubated
for 30 min at 56 uC. Nucleic acid was extracted with phenol/
chloroform and resuspended in 50 ml 10 mM Tris/HCl (pH 7.5)
followed by library preparation for de novo pyrosequencing in a
Genome Sequencer FLX system (454 Life Sciences) with the
manufacturer’s recommendations and reagents. Briefly, extracted
viral RNA was fragmented, reverse transcribed and ligated to
oligonucleotide adaptors containing MID labels. The MID-labelled
viral cDNA samples were pooled and used to prepare sequencing
beads via Roche’s GS-FLX standard chemistry emulsion-based PCR.
Each pool contained viral cDNA from three to five different viruses.
Prepared beads were loaded onto 16 regions on a GS-FLX standard
chemistry pico-titre plate according to manufacturer’s recommenda-
tions and sequenced using the GS-FLX LR 70 standard chemistry.
Sequencing reads were compared to an influenza database created
from .85000 influenza sequences extracted from GenBank in
December, 2008. Using the BLAST results, influenza-specific sequen-
cing reads were extracted and subsequently assembled with the Roche
GS de novo Assembler (Newbler) version 2.0 software. Gene segments
with large gaps were closed by traditional primer based sequencing
using an ABI 3100 (Applied Biosystem) genetic analyser. The
sequence contigs were analysed using SeqMan (DNASTAR). The 2008
H1 sequences generated were deposited into GenBank with the
accession numbers proceeding from segment 1 to segment 8 as
presented in Table 2. Human and swine influenza virus sequences
adopted for the phylogenetic analysis were retrieved from the
Influenza Virus Sequence Database (http://www.ncbi.nlm.nih.gov/
genomes/FLU/Database/nph-select.cgi?go=database). For the HA and
NA analyses, sequences recruitment was restricted to those exhibiting
a minimum of 1000 nt. Sequence alignment for each individual gene
segment and phylogenetic analyses were conducted using MEGA
version 4 and the evolutionary distances were computed using the
maximum composite likelihood method. Statistical support was
provided by bootstrapping over 1000 replicates and bootstrap values
.70 are indicated at the corresponding node (Tamura et al., 2007).
Animals, serological assay and antigenic cartography. Four-
week-old cross-bred pigs were obtained from a herd free of both
influenza virus and porcine reproductive and respiratory syndrome
virus (PRRSV) infections. Animals were housed, treated and
screened for anti-influenza antibodies as described previously
(Vincent et al., 2009b). Two pigs per virus were immunized with
inactivated virus combined with commercial adjuvant by an
intramuscular route. Two doses of vaccine were given approximately
2–3 weeks apart; pigs with HI titres ,1:80 after the second dose
were given a third dose of vaccine prior to final blood collection. At
the end of the vaccination period, pigs were humanely euthanized
with pentobarbital (Sleepaway; Fort Dodge Animal Health, Fort
Dodge, IA) approximately 2 weeks after the final vaccination for
blood collection.
Sera were heat inactivated at 56 uC and treated as described elsewhere
(Vincent et al., 2010) and the HI assays were performed with turkey
red blood cells with standard techniques (WHO Manual on Animal
Influenza Diagnosis and Surveillance). The reciprocal of the ratio
between heterologous and homologous HI titres for individual
serum samples was calculated to indicate the fold-change between
heterologous and homologous reactions.
The quantitative analyses of the antigenic properties of 2008 H1
viruses were performed using antigenic cartography. In an antigenic
map, the distance between antiserum point S and antigen point A
corresponds to the difference between the log2 of the maximum titre
observed for antiserum S against any antigen and the log2 of the titre
for antiserum S against antigen A. Therefore, each titre in an HI table
can be thought of as specifying a target distance for the points in an
antigenic map. Modified multidimensional scaling methods are then
used to arrange the antigen and antiserum points in an antigenic map
to best satisfy all the target distances specified by the HI data. The
result is a map in which the distance between points best represents
antigenic distance as measured by the HI assay. Because antisera are
tested against multiple antigens, and antigens tested against multiple
antisera, many measurements are used to determine the position of
the antigen and antiserum points in an antigenic map, thus
potentially increasing the accuracy of point placement beyond that
of individual HI measurements.
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